혈압계 시장 : 규모, 점유율, 성장, 업계 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of blood pressure monitors Market

The global blood pressure monitors market is witnessing robust growth driven by the rising prevalence of cardiovascular diseases, technological advancements in monitoring devices, and an increasing shift toward home healthcare. The market was valued at USD 2.15 billion in 2025, projected to grow to USD 2.33 billion in 2026, and is expected to reach USD 4.83 billion by 2034, exhibiting a CAGR of 9.5% during the forecast period. North America dominated the market in 2025 with a 42.70% share, attributed to the high prevalence of hypertension, strong presence of leading market players, and widespread availability of advanced diagnostic devices.

Blood pressure monitors are essential tools for measuring systolic and diastolic blood pressure in individuals. These devices are increasingly adopted for diagnosing, monitoring, and managing cardiovascular disorders such as hypertension and cardiac arrhythmia. According to the World Health Organization (WHO), around 17.9 million people died from cardiovascular diseases globally in 2019, of which 85% were due to heart attacks and strokes. The growing incidence of cardiovascular disorders, along with increasing healthcare expenditure in emerging countries, is fueling the demand for blood pressure monitors worldwide.

The COVID-19 pandemic temporarily affected the market, as demand surged in emergency departments for monitoring COVID-19 patients' vitals. However, as the situation normalized, growth stabilized in 2021. During the pandemic, major players such as Omron Healthcare, Hill-Rom Holdings, and GE Healthcare witnessed revenue growth due to increased device utilization.

Market Trends

A key trend is the shift toward home healthcare settings. With frequent monitoring required for conditions such as hypertension, patients are increasingly adopting home-based blood pressure monitors. Telehealth integration and wearable digital devices allow continuous monitoring and data transfer, improving patient compliance. For example, Aktiia SA launched a 24/7 automated BP monitoring system in January 2021, enabling accurate blood pressure tracking even during sleep.

Market Drivers

The primary driver is the rising prevalence of cardiovascular disorders. In 2023, WHO reported 1.28 billion adults aged 30-79 years worldwide had hypertension, with the majority residing in low- and middle-income countries. The aging global population further increases the patient pool, particularly in countries like China, India, and Japan, creating a sustained demand for monitoring devices.

Government initiatives and awareness campaigns also boost adoption. For instance, in 2021, the NHS in the UK distributed free BP monitors to 220,000 patients with uncontrolled hypertension, emphasizing preventive care. Manufacturers are responding by launching devices with advanced features, such as Bluetooth connectivity and integration with mobile health applications. For example, in October 2020, Omron Healthcare launched HEM-7361T and HEM-7156 with wireless connectivity in Indonesia.

Restraining Factors

High costs of advanced devices and lack of awareness in certain emerging regions hinder market growth. A 2023 study indicated that home BP monitoring in Australia costs around USD 6,400 per year per person, while clinic monitoring costs USD 6,700. Additionally, device validation issues have been reported; a 2020 study found 93.4% of 972 online-sold BP monitors in Australia were non-validated, reducing adoption among healthcare providers and patients.

Market Segmentation

By Product

The market is segmented into devices and accessories. The devices segment dominated with an 80.69% share in 2026, driven by widespread use in clinical and home settings. This segment includes sphygmomanometers, digital BP monitors, and ambulatory BP monitors. Accessories, such as cuffs and transducers, are growing due to increasing device adoption and the demand for disposable components.

By End-User

Home healthcare dominated with 69.96% market share in 2026, reflecting increased patient preference for self-monitoring and digital devices. The hospitals & clinics segment is growing steadily, supported by expanding healthcare infrastructure, while the others segment shows moderate growth through research and innovative device launches.

Regional Insights

• North America: Valued at USD 1.00 billion in 2025, projected at USD 0.89 billion in 2026, led by the U.S. with 119.9 million hypertension patients and strong presence of major players.
• Europe: Moderate growth; UK and Germany projected to reach USD 0.11 billion and USD 0.12 billion by 2026, supported by R&D and digital health initiatives.
• Asia Pacific: High growth potential due to aging population and healthcare investments; Japan, China, and India projected at USD 0.16, 0.18, and 0.06 billion by 2026.
• Latin America & Middle East & Africa: Moderate growth fueled by awareness programs, reimbursement support, and emerging healthcare infrastructure.

Key Players and Developments

Leading players include Omron Healthcare (Japan), Hill-Rom Holdings (U.S.), Nihon Kohden (Japan), Koninklijke Philips (Netherlands), Masimo (U.S.), Beurer GmbH (Germany), GE Healthcare (U.S.), American Diagnostic Corporation (Europe), and SunTech Medical (U.S.).

Recent developments:

• June 2023 - SunTech Medical installed Oscar 2 ABPM in the Philippines.
• August 2023 - Omron Healthcare and Glenmark Pharmaceuticals partnered in India for hypertension awareness.
• September 2022 - Garmin launched a smart home BP monitor.

Conclusion

The blood pressure monitors market is set to grow from USD 2.15 billion in 2025 to USD 4.83 billion by 2034, driven by rising cardiovascular disorders, home healthcare adoption, technological advancements, and government awareness programs. Despite high costs and validation challenges, growing patient awareness and product innovation ensure sustained market expansion.

Segmentation By Product

• Devices
  • Sphygmomanometer
  • Digital BP Monitors
  • Ambulatory BP Monitors
• Accessories
  • Blood Pressure Cuffs
  • Transducers
  • Others

By End-user

• Hospitals & Clinics
• Home Healthcare
• Others

By Region

• North America (By Product, By End-user, and by Country)
  • U.S.
  • Canada
• Europe (By Product, By End-user, and by Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific (By Product, By End-user, and by Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Product, By End-user, and by Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, By End-user, and by Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Hypertension - by Key Countries/ Region, 2022/2025
• 4.2. Overview of New Product Launches
• 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.4. Impact of COVID-19 on the Market

5. Global Blood Pressure Monitors Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Devices
    • 5.1.1.1. Sphygmomanometer
    • 5.1.1.2. Digital BP Monitors
    • 5.1.1.3. Ambulatory BP Monitors
  • 5.1.2. Accessories
    • 5.1.2.1. Blood Pressure Cuffs
    • 5.1.2.2. Transducers
    • 5.1.2.3. Others
• 5.2. Market Analysis, Insights and Forecast - By End-user
  • 5.2.1. Hospitals & Clinics
  • 5.2.2. Home Healthcare
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Blood Pressure Monitors Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Devices
    • 6.1.1.1. Sphygmomanometer
    • 6.1.1.2. Digital BP Monitors
    • 6.1.1.3. Ambulatory BP Monitors
  • 6.1.2. Accessories
    • 6.1.2.1. Blood Pressure Cuffs
    • 6.1.2.2. Transducers
    • 6.1.2.3. Others
• 6.2. Market Analysis, Insights and Forecast - By End-user
  • 6.2.1. Hospitals & Clinics
  • 6.2.2. Home Healthcare
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Blood Pressure Monitors Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Devices
    • 7.1.1.1. Sphygmomanometer
    • 7.1.1.2. Digital BP Monitors
    • 7.1.1.3. Ambulatory BP Monitors
  • 7.1.2. Accessories
    • 7.1.2.1. Blood Pressure Cuffs
    • 7.1.2.2. Transducers
    • 7.1.2.3. Others
• 7.2. Market Analysis, Insights and Forecast - By End-user
  • 7.2.1. Hospitals & Clinics
  • 7.2.2. Home Healthcare
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. UK
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Rest of Europe

8. Asia Pacific Blood Pressure Monitors Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Devices
    • 8.1.1.1. Sphygmomanometer
    • 8.1.1.2. Digital BP Monitors
    • 8.1.1.3. Ambulatory BP Monitors
  • 8.1.2. Accessories
    • 8.1.2.1. Blood Pressure Cuffs
    • 8.1.2.2. Transducers
    • 8.1.2.3. Others
• 8.2. Market Analysis, Insights and Forecast - By End-user
  • 8.2.1. Hospitals & Clinics
  • 8.2.2. Home Healthcare
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Rest of Asia Pacific

9. Latin America Blood Pressure Monitors Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Devices
    • 9.1.1.1. Sphygmomanometer
    • 9.1.1.2. Digital BP Monitors
    • 9.1.1.3. Ambulatory BP Monitors
  • 9.1.2. Accessories
    • 9.1.2.1. Blood Pressure Cuffs
    • 9.1.2.2. Transducers
    • 9.1.2.3. Others
• 9.2. Market Analysis, Insights and Forecast - By End-user
  • 9.2.1. Hospitals & Clinics
  • 9.2.2. Home Healthcare
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America

10. Middle East & Africa Blood Pressure Monitors Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Devices
    • 10.1.1.1. Sphygmomanometer
    • 10.1.1.2. Digital BP Monitors
    • 10.1.1.3. Ambulatory BP Monitors
  • 10.1.2. Accessories
    • 10.1.2.1. Blood Pressure Cuffs
    • 10.1.2.2. Transducers
    • 10.1.2.3. Others
• 10.2. Market Analysis, Insights and Forecast - By End-user
  • 10.2.1. Hospitals & Clinics
  • 10.2.2. Home Healthcare
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.3.1. GCC Countries
  • 10.3.2. South Africa
  • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Koninklijke Philips N.V.Overview
    • 11.2.1.1. Products & services
    • 11.2.1.2. SWOT Analysis
    • 11.2.1.3. Recent Developments
    • 11.2.1.4. Strategies
    • 11.2.1.5. Financials (Based on Availability)
  • 11.2.2. HILL-ROM HOLDINGS, INC.
    • 11.2.2.1. Products & services
    • 11.2.2.2. SWOT Analysis
    • 11.2.2.3. Recent Developments
    • 11.2.2.4. Strategies
    • 11.2.2.5. Financials (Based on Availability)
  • 11.2.3. Omron Healthcare, Inc.
    • 11.2.3.1. Products & services
    • 11.2.3.2. SWOT Analysis
    • 11.2.3.3. Recent Developments
    • 11.2.3.4. Strategies
    • 11.2.3.5. Financials (Based on Availability)
  • 11.2.4. Masimo
    • 11.2.4.1. Products & services
    • 11.2.4.2. SWOT Analysis
    • 11.2.4.3. Recent Developments
    • 11.2.4.4. Strategies
    • 11.2.4.5. Financials (Based on Availability)
  • 11.2.5. Nihon Kohden Corporation
    • 11.2.5.1. Products & services
    • 11.2.5.2. SWOT Analysis
    • 11.2.5.3. Recent Developments
    • 11.2.5.4. Strategies
    • 11.2.5.5. Financials (Based on Availability)
  • 11.2.6. GE HealthCare
    • 11.2.6.1. Products & services
    • 11.2.6.2. SWOT Analysis
    • 11.2.6.3. Recent Developments
    • 11.2.6.4. Strategies
    • 11.2.6.5. Financials (Based on Availability)
  • 11.2.7. Beurer GmbH
    • 11.2.7.1. Products & services
    • 11.2.7.2. SWOT Analysis
    • 11.2.7.3. Recent Developments
    • 11.2.7.4. Strategies
    • 11.2.7.5. Financials (Based on Availability)
  • 11.2.8. American Diagnostic Corporation
    • 11.2.8.1. Products & services
    • 11.2.8.2. SWOT Analysis
    • 11.2.8.3. Recent Developments
    • 11.2.8.4. Strategies
    • 11.2.8.5. Financials (Based on Availability)
  • 11.2.9. SunTech Medical, Inc.
    • 11.2.9.1. Products & services
    • 11.2.9.2. SWOT Analysis
    • 11.2.9.3. Recent Developments
    • 11.2.9.4. Strategies
    • 11.2.9.5. Financials (Based on Availability)